Fruquintinib
Fruquintinib is an orally available, small molecule inhibitor of vascular endothelial growth factor receptors (VEGFRs), with potential anti-angiogenic and antineoplastic activities.

Catalog Number | T2656 |
Alternative Name(s) | HMPL-013 |
Research Area | Angiogenesis|||Tyrosine Kinase/Adaptors |
Molecular Formula | C21H19N3O5 |
CAS# | 1194506-26-7 |
SMILES | Cc1c(c2c(o1)cc(cc2)Oc1ncnc2cc(c(cc12)OC)OC)C(=O)NC |
Size | 50 mg |
Supplier Page | https://www.targetmol.com/compound/Fruquintinib |
Additional Information | https://www.targetmol.com/datasheet/T2656 |